Skip to main content
U.S. flag

An official website of the United States government

L-3-n-butylphthalide reduces tau phosphorylation and improves cognitive deficits in AβPP/PS1-Alzheimer’s transgenic mice

Bibliographic

Year of Publication:
2012
Contact PI Name:
Xiaoliang Wang
Contact PI Affiliation:
Pharmacology Department, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
Co-Authors:
Ying Peng, Yanli Hu, Shaofeng Xu, Pingping Li, Jiang Li, Li Lu, Hongyan Yang, Nan Feng, Ling Wang
Primary Reference (PubMED ID):
Funding Source:
National Science and Technology Major Special Project on Major New Drug Innovation of China
Program for New Century Excellent Talents in University
National Natural Science Foundation of China
Study Goal and Principal Findings:

L-3-n-butylphthalide (L-NBP), an extract from seeds of Apium graveolens Linn (Chinese celery), has been shown to have neuroprotective effects on cerebral ischemic, vascular dementia and amyloid-β (Aβ)-induced animal models by inhibiting oxidative injury, neuronal apoptosis and glial activation, regulating amyloid-β protein precursor (AβPP) processing and reducing Aβ generation. The aim of the present study was to examine the effect of L-NBP on learning and memory in AβPP and presenilin 1 (PS1) double-transgenic AD mouse model (AβPP/PS1) and the mechanisms of L-NBP in reducing Aβ accumulation and tau phosphorylation. Twelve-month old AβPP/PS1 mice were given 15 mg/kg L-NBP by oral gavage for 3 months. L-NBP treatment significantly improved the spatial learning and memory deficits compared to the vehicle-treated AβPP/PS1 mice, whereas L-NBP treatment had no effect on cerebral Aβ plaque deposition and Aβ levels in brain homogenates. However, we found an L-NBP-induced reduction of tau hyperphosphorylation at Ser199, Thr205, Ser396, and Ser404 sites in AβPP/PS1 mice. Additionally, the expressions of cyclin-dependent kinase and glycogen synthase kinase 3β, the most important kinases involved in tau phosphorylation, were markedly decreased by L-NBP treatment. The effects of L-NBP on decreasing tau phosphorylation and kinases activations were further confirmed in neuroblastoma SK-N-SH cells overexpressing wild-type human AβPP695 (SKN-SH AβPPwt). L-NBP shows promising candidate of multi-target neuronal protective agent for the treatment of Alzheimer’s disease.

Therapeutic Agent

Therapeutic Information:
Therapy Type:
Natural Product
Therapeutic Agent:
L-3-n-Butylphthalide
Therapeutic Target:
Multi Target

Animal Model

Model Information:
Species:
Mouse
Model Type:
APPxPS1
Strain/Genetic Background:
Not Reported

Experimental Design

Is the following information reported in the study?:
Power/Sample Size Calculation
Randomized into Groups
Blinded for Treatment
Blinded for Outcome Measures
Pharmacokinetic Measures
Pharmacodynamic Measures
Toxicology Measures
ADME Measures
Biomarkers
Dose
Formulation
Route of Delivery
Duration of Treatment
Frequency of Administration
Age of Animal at the Beginning of Treatment
Age of Animal at the End of Treatment
Sex as a Biological Variable
Study Balanced for Sex as a Biological Variable
Number of Premature Deaths
Number of Excluded Animals
Statistical Plan
Genetic Background
Inclusion/Exclusion Criteria Included
Conflict of Interest

Outcomes

Outcome Measured
Outcome Parameters
Behavioral
Cued Task
Morris Water Maze
Motor Function
Swimming Speed
Histopathology
beta Amyloid Deposits
beta Amyloid Load
Diffuse Plaques
Fibrillar Plaques
Dense-core/Compact Plaques
Biochemical
Brain-Buffer Soluble beta Amyloid Peptide 42
Brain-Guanidine Soluble beta Amyloid Peptide 42
Cyclin-Dependent Kinase 5 (CDK5)
phospho-Cyclin-Dependent Kinase 5 (phospho-CDK5)
phospho-Glycogen Synthase Kinase 3 alpha (phospho-GSK3 alpha)
Glycogen Synthase Kinase 3 beta (GSK3 beta)
phospho-Glycogen Synthase Kinase 3 beta (phospho-GSK3 beta)
phospho-Tau
Immunochemistry
beta Amyloid Load
Brain-beta Amyloid Deposits
Toxicology
Body Weight
Outcomes Notes:
Visible cued task was performed to ensure that test mice did not have any basic learning or visual acuity impairments, though this data are not shown.